Showing 1 - 10 of 3,956
in the United States to study the impacts on online purchases of naloxone, an opioid overdose reversal drug. Advertising …
Persistent link: https://www.econbiz.de/10014468229
Despite efforts to address the opioid crisis, opioid-related overdoses remain a significant contributor to mortality. State efforts to reduce overdose deaths by removing barriers to naloxone have recently focused on pharmacy channels, but the specifics of these laws and the contexts in which...
Persistent link: https://www.econbiz.de/10014250160
of fentanyl smuggling occurs via legal trade flows, with a positive relationship between state-level imports and drug …
Persistent link: https://www.econbiz.de/10014437016
We examine the effects of must-access prescription drug monitoring programs (PDMPs) and recent regulations limiting the …
Persistent link: https://www.econbiz.de/10012660049
The fivefold increase in opioid deaths between 2000 and 2017 rivals even the COVID-19 pandemic as a health crisis for America. Why did it happen? Measures of demand for pain relief - physical pain and despair - are high but largely unchanging. The primary shift is in supply, primarily of new...
Persistent link: https://www.econbiz.de/10012533422
previous drug epidemics; this finding is consistent with the pharmacological difference between opioids and stimulant … substances (e.g., cocaine) that dominated earlier drug epidemic periods characterized by higher levels of crime. Through the …
Persistent link: https://www.econbiz.de/10013191077
Fragmented healthcare received from many different physicians results in higher costs and lower quality, but does it contribute to dangerous opioid prescribing? The effect is theoretically ambiguous because fragmentation can trigger costly coordination failures but also permits greater...
Persistent link: https://www.econbiz.de/10013191086
rebates and discounts they negotiate for drug insurance plans serving Medicare beneficiaries. This policy would significantly … change drug pricing and utilization and shift billions of dollars annually from patients and taxpayers to drug manufacturers …
Persistent link: https://www.econbiz.de/10014372424
We investigate whether increased racial diversity of clinical trial principal investigators could increase the enrollment of Black patients, which currently lags population and disease-burden shares. We conducted a survey experiment in which respondents were shown a photo of a current NIH...
Persistent link: https://www.econbiz.de/10014372489
generic entry only if all patents on a drug were public-sector patents. In this paper, we examine the feasibility of using … march-in rights to lower pharmaceutical prices by examining patents on drugs approved by the U.S. Food and Drug …
Persistent link: https://www.econbiz.de/10014512071